Skip to main content
. Author manuscript; available in PMC: 2015 Jan 16.
Published in final edited form as: Breast Cancer Res Treat. 2012 Jun 8;134(2):649–659. doi: 10.1007/s10549-012-2106-5

Fig. 2.

Fig. 2

Differential effects of PARP inhibitors on PARP inhibition, DNA damage, and apoptosis in TNBC cells. Effects of AG-014699, AZD-2281, ABT-888, or BSI-201 on the levels of PAR, γ-H2AX, and PARP cleavage in MDA-MB-468, MDA-MB-231, and Cal-51 cells. Cells were treated with the indicated concentrations of PARP inhibitors in the presence of 5 % FBS-supplemented DMEM medium for 72 h